AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 90 filers reported holding AVROBIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | -50.5% | 137,908 | +2.8% | 0.00% | – |
| Q4 2021 | $440,000 | -58.4% | 134,127 | -21.6% | 0.00% | – |
| Q3 2021 | $1,057,000 | -29.4% | 170,996 | +1.6% | 0.00% | – |
| Q2 2021 | $1,497,000 | -11.9% | 168,364 | +25.8% | 0.00% | -100.0% |
| Q1 2021 | $1,699,000 | -18.3% | 133,847 | -10.3% | 0.00% | 0.0% |
| Q4 2020 | $2,079,000 | +11.1% | 149,140 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $1,871,000 | -24.5% | 143,738 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $2,478,000 | +12.2% | 142,014 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,209,000 | -22.2% | 141,996 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $2,840,000 | +25.6% | 141,108 | -11.9% | 0.00% | 0.0% |
| Q3 2019 | $2,261,000 | +114.5% | 160,110 | +147.1% | 0.00% | – |
| Q2 2019 | $1,054,000 | – | 64,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |